ASC Expansion: How to Grow Without Sacrificing Margin
Authors:
Jess Thurston, Vice President, Client Development at nimble solutions
Scott Allen, Sr. Vice President, Managed Care Contracting at nimble solutions
Growth in the ASC market isn’t slowing down — and 2026 is shaping up to be another pivotal year.
As payers continue shifting procedures out of hospitals and Medicare expands the ASC-approved list, opportunity is everywhere. But here’s the hard truth: more volume does not automatically mean more profit. In fact, expanding too quickly — without contract readiness, clean data, and a disciplined revenue strategy — can create margin erosion that’s hard to unwind.
In a recent webinar hosted in partnership with Ambulatory Surgery Center News, experts from nimble solutions broke down exactly what ASC leaders must consider before adding new specialties, launching a de novo center, or renegotiating payer contracts.
Here’s what you need to know.
The Opportunity Is Real — But So Are the Risks
Employers and payers increasingly recognize the cost and quality advantages of outpatient surgery. More procedures are migrating to ASCs. Complex cases like total joints and spine are becoming more common. Physician recruitment is accelerating. But margins remain thin.
Without proper modeling and payer strategy, centers can:
- Add service lines that lose money
- Sign contracts that cap growth
- Open de novo centers without adequate runway
- Underestimate anesthesia and implant costs
- Miss underpayments at scale
The result? High case volume… with disappointing financial performance.
Adding a New Service Line: Start With the Basics
Before you greenlight a new specialty or recruit a surgeon, answer these questions:
1. Do You Have Complete, Organized Contracts?
You need:
- Fully executed agreements and amendments
- Current fee schedules and crosswalks
- Clear language on carve-outs, groupers, and device-intensive procedures
- Notification requirements for service changes
Missing or outdated contracts can derail your modeling before you even start.
2. Have You Modeled the Top CPT Codes?
Pull the physician’s most frequent procedures and model:
- Current reimbursement by payer
- Implant/device costs
- Anesthesia implications
- Overhead allocation
- Frequency and payer mix
Even reviewing the top 10 codes can capture the majority of revenue exposure.
3. Are You Prepared Clinically and Financially?
Adding total joints or complex spine cases requires:
- Documentation readiness
- Authorization workflows
- Pre-surgery requirement alignment
- Clinical pathway compliance
Revenue cycle and clinical operations must move together. If they don’t, denials follow.
De Novo ASCs: The Timeline Most Leaders Underestimate
Opening a new ASC is exciting — but the payer timeline is longer than most expect.
Here’s a realistic sequence:
- Construction complete
- Apply for accreditation
- Pass accreditation
- Begin payer credentialing
- Wait 30–90+ days per payer
- Receive contract offer
- Negotiate
- Finalize agreements
This can stretch 12–18 months before your largest commercial payer is in network.
During that time, you must:
- Plan out-of-network strategy carefully
- Understand IDR implications
- Prepare physician contracts
- Structure anesthesia appropriately
- Build data infrastructure from day one
Rushing to sign a weak contract just to “get revenue flowing” often costs far more long term.
Chargemaster Strategy: Not Just “5x Medicare”
A common mistake? Setting charges as a flat multiple of Medicare.
That approach ignores:
- Device-intensive cases
- Grouper limitations
- Percentage-of-billed contracts
- Procedures without Medicare benchmarks
Poor charge strategy can result in:
- Underpayments
- Patient dissatisfaction from inflated bills
- Contractual conflicts
- Revenue left on the table
An annual chargemaster review — comparing loaded system charges to allowed amounts and benchmarks — is critical, especially after adding new procedures.
Anesthesia: The Overlooked Financial Variable
Anesthesia modeling must be part of any expansion discussion.
Questions to evaluate:
- Separate tax ID vs. bundled arrangements?
- Stipend requirements?
- Network participation alignment?
- Volume projections sufficient to support coverage?
Some payer contracts penalize facilities if anesthesia providers are out of network. Others require notification or rate alignment.
Ignoring anesthesia during growth planning is one of the most common blind spots in ASC expansion.
Protecting Revenue: Underpayments, Variances & Scorecards
Growth without oversight equals leakage.
High-performing ASCs are:
- Running payment variance analysis
- Tracking payer scorecards
- Monitoring contract loading accuracy
- Auditing front-end insurance classification
- Reviewing authorization workflows annually
Payers do not always load contracts correctly. Underpayments happen daily. Without a defined recovery process, missed revenue compounds quickly.
The Leverage Question: What Makes You Different?
In today’s environment, simply being “another ASC” isn’t enough.
To negotiate effectively, you need:
- Clean, defensible data
- A clear value story
- Market awareness
- Volume leverage (when applicable)
- Understanding of self-funded vs. fully funded plans
- Diversified revenue streams (e.g., workers’ comp, IDR where appropriate)
If you can’t articulate your unique value — quality outcomes, access, employer impact — negotiations stall at 1–2% increases.
Data is your leverage.
The Bottom Line: Expansion Is a Financial Strategy — Not Just a Clinical One
ASC growth in 2026 presents enormous upside. But success depends on preparation.
Before expanding, ensure you have:
- Clean systems and payer profiles
- Organized contracts and modeling tools
- Clear de novo runway expectations
- Structured anesthesia strategy
- Annual chargemaster discipline
- Payment variance oversight
- Defined out-of-network protocols
Cash per case is what sustains you.
Click to watch the full webinar.
Be sure to follow us on LinkedIn for the latest industry news and updates!
